HEPATOLOGY

Scope & Guideline

Transforming liver health with groundbreaking insights.

Introduction

Explore the comprehensive scope of HEPATOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore HEPATOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0270-9139
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1981 to 2024
AbbreviationHEPATOLOGY / Hepatology
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Hepatology' focuses on advancing the understanding, prevention, diagnosis, and treatment of liver diseases through rigorous research and clinical studies. Its scope encompasses a broad range of topics related to hepatology, including but not limited to viral hepatitis, liver cancer, fatty liver disease, and liver transplantation. The journal aims to disseminate high-quality research findings that can influence clinical practice and improve patient outcomes.
  1. Viral Hepatitis Research:
    This area includes studies on the epidemiology, pathogenesis, and treatment of hepatitis viruses (A, B, C, D, and E), focusing on novel antiviral therapies and their clinical implications.
  2. Liver Cancer and Oncology:
    Research on hepatocellular carcinoma (HCC) and cholangiocarcinoma, including mechanisms of tumorigenesis, therapeutic strategies, and outcomes of various treatment modalities.
  3. Liver Disease Mechanisms:
    Investigations into the cellular and molecular mechanisms underlying liver diseases such as non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and autoimmune liver conditions.
  4. Transplantation and Regenerative Medicine:
    Studies focused on liver transplantation, including donor selection, post-transplant outcomes, and the role of stem cells and organoids in liver regeneration.
  5. Clinical Guidelines and Practice:
    The journal publishes consensus guidelines and practice recommendations to improve the management of liver diseases, emphasizing evidence-based approaches.
  6. Innovative Diagnostic Techniques:
    Research utilizing advanced diagnostic modalities such as imaging techniques, serum biomarkers, and non-invasive fibrosis assessment methods for better disease characterization.
  7. Public Health and Epidemiology:
    Articles addressing the epidemiological aspects of liver diseases, including the impact of lifestyle factors, health disparities, and public health initiatives for prevention and management.
Recent publications in 'Hepatology' indicate several trending and emerging themes that reflect the evolving landscape of liver disease research. These themes highlight innovative approaches, novel therapeutic strategies, and a comprehensive understanding of liver disease mechanisms.
  1. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
    Research on MAFLD is gaining momentum, emphasizing the need for updated diagnostic criteria and treatment strategies that address the metabolic aspects of liver disease.
  2. Artificial Intelligence in Hepatology:
    The integration of AI and machine learning techniques for diagnosing liver diseases, predicting outcomes, and personalizing treatment regimens is becoming increasingly prominent.
  3. Personalized Medicine Approaches:
    Emerging studies focusing on tailoring therapies based on individual patient characteristics, genetic profiles, and specific disease phenotypes are trending.
  4. Non-Invasive Diagnostic Modalities:
    There is a marked increase in research on non-invasive techniques for diagnosing liver conditions, including transient elastography, MRI-based assessments, and blood-based biomarkers.
  5. Gut-Liver Axis Research:
    The exploration of the gut microbiome's role in liver disease pathogenesis and treatment responses is an emerging area of interest, linking gastrointestinal health to liver outcomes.
  6. Longitudinal Studies and Real-World Evidence:
    There is a growing trend towards longitudinal studies that provide real-world evidence on the effectiveness of therapies and the natural history of liver diseases.
  7. Public Health Interventions:
    Research focusing on the impact of public health policies and community-based interventions for liver disease prevention and management is gaining traction.

Declining or Waning

While 'Hepatology' has consistently covered various aspects of liver diseases, certain research areas appear to be declining in prominence based on recent publications. This may reflect shifting priorities within the field, advancements in understanding, or the saturation of existing knowledge in those areas.
  1. Traditional Liver Biopsy Techniques:
    There has been a noticeable decline in studies focused on traditional liver biopsy methods as non-invasive techniques for assessing liver fibrosis gain popularity and acceptance.
  2. Alcohol-Induced Liver Disease:
    Although still an important topic, research specifically focused on classic alcohol-induced liver disease may be waning as attention shifts towards broader metabolic dysfunction-associated liver diseases (MASH) and their multifactorial causes.
  3. Basic Science Studies:
    The journal has seen fewer purely basic science studies as there is a growing emphasis on translational research that can directly impact clinical practice and patient care.
  4. Viral Hepatitis Monotherapy Studies:
    Research focusing solely on monotherapy for hepatitis treatments is declining in favor of combination therapies that target multiple pathways and improve treatment efficacy.
  5. Outdated Diagnostic Biomarkers:
    Research on older biomarkers for liver disease diagnosis is decreasing as newer, more effective biomarkers are developed and validated.

Similar Journals

Hepatology Communications

Driving discoveries in liver disease and treatment.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Hepatology Communications, published by Lippincott Williams & Wilkins, serves as a pioneering platform in the field of hepatology, dedicated to advancing the understanding of liver diseases and treatments. Since its inception in 2017, this open access journal has rapidly gained recognition, achieving an impressive Q1 ranking in Hepatology as of 2023, and appealing to a diverse audience of researchers, clinicians, and students alike. With its focus on high-quality research and clinical studies, the journal aims to facilitate impactful discussions and disseminate vital findings that address the challenges faced in liver health. Operating out of the United States, and accessible globally, Hepatology Communications is committed to fostering a collaborative research environment and enhancing the visibility of scholarly work in hepatology, ultimately driving forward innovations in patient care and treatment strategies.

Canadian Liver Journal

Exploring New Frontiers in Liver Disease Management.
Publisher: UNIV TORONTO PRESS INCISSN: Frequency: 4 issues/year

Canadian Liver Journal, published by University of Toronto Press Inc., offers a dedicated platform for the dissemination of cutting-edge research in the field of Hepatology. With an E-ISSN of 2561-4444, this journal plays a pivotal role in advancing knowledge related to liver diseases and therapies, currently ranked in the 3rd quartile (Q3) for the 2023 category in Hepatology—a reflection of its growing influence in the biomedical research community. The journal, which has been in circulation since 2018 and sets its sights on contributing valuable insights until 2024, aims to engage researchers, clinicians, and students alike by providing a rigorous peer-reviewed environment for sharing findings, case studies, and reviews pertinent to liver health. Through its commitment to excellence and scholarly impact, the Canadian Liver Journal serves as an essential resource for those dedicated to combating liver diseases and enhancing patient care.

BMJ Open Gastroenterology

Advancing Gastroenterology Through Open Access Research
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

Annals of Hepatology

Advancing liver research, one article at a time.
Publisher: ELSEVIER ESPANAISSN: 1665-2681Frequency: 6 issues/year

Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.

JHEP Reports

Unlocking innovations in gastroenterology and beyond.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.

Clinics in Liver Disease

Unveiling the complexities of hepatology for better care.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.

Hepatobiliary Surgery and Nutrition

Pioneering research in liver and biliary wellness.
Publisher: AME PUBLISHING COMPANYISSN: 2304-3881Frequency: 6 issues/year

Hepatobiliary Surgery and Nutrition is a leading journal dedicated to advancing the fields of hepatobiliary surgery and nutritional science, published by AME Publishing Company. With a commitment to disseminate high-quality research, this journal serves as a vital platform for clinicians, researchers, and students alike to share their findings and insights related to liver and biliary health. The journal operates under an Open Access model, ensuring that cutting-edge research is readily available to a global audience. Although specific rankings and impact factors are currently not provided, the journal's focus on innovative surgical techniques and nutritional strategies underscores its importance in improving patient outcomes and shaping future practices in hepatobiliary medicine. Situated in Hong Kong, Hepatobiliary Surgery and Nutrition invites submissions that push the boundaries of knowledge in these crucial areas, fostering a collaborative environment for advancement in surgery and nutrition.

Translational Gastroenterology and Hepatology

Advancing Patient Outcomes through Translational Research.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Egyptian Liver Journal

Exploring breakthroughs in liver disease research.
Publisher: SPRINGEROPENISSN: 2090-6218Frequency: 1 issue/year

The Egyptian Liver Journal, ISSN 2090-6218, is a vital resource for the hepatology community, published by SPRINGEROPEN. Since its establishment in 2012, this journal has served as a platform for disseminating significant findings in liver research, with an emphasis on enhancing understanding and treatment of liver diseases. Recognized with a Q3 ranking in Hepatology for 2023, the Egyptian Liver Journal aims to bridge the gap between research and clinical practice through its commitment to open access, fostering a global exchange of knowledge without barriers since 2019. With a focus on innovative studies, reviews, and clinical guidelines, the journal appeals to a diverse audience of researchers, clinicians, and students dedicated to advancing liver health. Situated in the heart of the United States, this publication addresses the pressing issues within the field and encourages submissions that address the future of liver care and treatment.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Advancing knowledge in gastrointestinal and liver health.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.